Investor Relations – Merchavia

Overview

Company Profile

Presentation

Company Presentation

Reports

Immediate Reports

Financial

Financial Reports

Management

Management

Stock

Stock Chart

FAQ

FAQ

Alert

Mail Alert

Contact

Contact IR

Stock Quote

Tel Aviv: MRHL

93.9

Price

-2.8%

Change percentage

-2.7

Change

92.9

90

Last Update:28/02/2021

at:13:45

Presentations

Financial Reports

Immediate Reports

Cardiacsense (approximately 5.67%), Receives CE approval for the marketing of a medical watch that it opened in Europe, expected date for FDA approval

10/02/2021

The investment of $ 150k as part of an investment round of about $ 17k in CDX according to about $ 112k (after), will hold 6.64%

07/02/2021

A round of fundraising in Cardiacsense (about 5.8%) – the debtor will invest $ 250, hold about 5.95% of the capital, B. Control will participate

04/02/2021

EFA (approximately 7.9%), began an experiment in collaboration with Maccabi and the Medical Campus to validate the data reported by the RevDx device developed by it

31/01/2021

Read more

Investors News

CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation

10/02/2021

Globes: 32 million distribution agreement for Cardiacsens from Merchavia Group

08/06/2020

Buinees Today: Israel’s CardiacSense signs $32.4 million deal to sell medical watches in India

08/06/2020

Yahoo Finance: Israeli tech firm to sell $32.4 million in medical watches in India

07/06/2020

Read more

Mail Alert

Subscribe to Receive Notifications by Email:

Stock Price

Tel Aviv: MRHL

93.9

Price

-2.8%

Change percentage

-2.7

Change

92.9

90

Last Update:28/02/2021

at:13:45